Joel Skoletsky
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 5
-
- Cystic Fibrosis Research Advances 2
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Anthony P. Shuber (8 shared papers)Kevin A. Boynton (2 shared papers)Stephen N. Thibodeau (1 shared paper)Douglas W. Mahoney (1 shared paper)William E. Pierceall (1 shared paper)Jonathan J. Harrington (1 shared paper)David A. Ahlquist (1 shared paper)Katherine Wood Klinger (3 shared papers)
- Journals
- PLoS ONE (3 papers)Human Molecular Genetics (3 papers)Gastroenterology (1 paper)Annals of Oncology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Joel Skoletsky
13 papers receiving 2.1k citations
Joel Skoletsky's Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 471
- Oncology 780
- Pathology and Forensic Medicine 269
- Genetics 242
- Molecular Biology 517
Countries citing papers authored by Joel Skoletsky
This map shows the geographic impact of Joel Skoletsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Skoletsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Skoletsky more than expected).
Fields of papers citing papers by Joel Skoletsky
This network shows the impact of papers produced by Joel Skoletsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Skoletsky. The network helps show where Joel Skoletsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Skoletsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 440 | |
| 2 | Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin Hit paper breakdown → | 2020 | 382 |
| 3 | 1993 | 367 | |
| 4 | 2005 | 312 | |
| 5 | Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors Hit paper breakdown → | 2022 | 260 |
| 6 | 2006 | 208 | |
| 7 | 1993 | 90 | |
| 8 | 2004 | 63 | |
| 9 | 1997 | 56 | |
| 10 | 1996 | 45 | |
| 11 | 2022 | 17 | |
| 12 | 2020 | 3 | |
| 13 | 2025 | 2 |
About Joel Skoletsky
Joel Skoletsky is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pediatrics, Perinatology and Child Health and Genetics, having authored 13 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Screening and Detection (3 papers), Cystic Fibrosis Research Advances (2 papers), Lung Cancer Treatments and Mutations (2 papers), Epigenetics and DNA Methylation (1 paper), Prenatal Screening and Diagnostics (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Cancer Research (471 citations), Oncology (780 citations), Pathology and Forensic Medicine (269 citations), Genetics (242 citations) and Molecular Biology (517 citations). Joel Skoletsky has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Anthony P. Shuber, Kevin A. Boynton, Stephen N. Thibodeau, Douglas W. Mahoney, William E. Pierceall, Jonathan J. Harrington, David A. Ahlquist, Katherine Wood Klinger, Henry L. Dorkin and David R. Witt. Their work appears in journals such as PLoS ONE, Human Molecular Genetics, Gastroenterology, Annals of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.